BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 21, 2010
View Archived Issues
U.S. DoD funds Tekmira's development of RNAi agent against Ebola virus infection
Read More
New HIF-1-alpha activators claimed by sanofi-aventis
Read More
Ziopharm begins phase III palifosfamide trial in metastatic soft tissue sarcoma
Read More
Scientists identify NAbs with potent HIV-1 neutralization activity
Read More
Hexyl/methyl aminolevulinate photodynamic therapy does not damage cervical tissue
Read More
SRT-2104 improves metabolic function and glucose homeostasis in mice with DIO
Read More
BI-10773 is safe and tolerated in healthy subjects and in type 2 diabetes
Read More
ARC-4558 topical gel reduces pain in phase IIb trial in diabetes-associated neuropathy
Read More
KAI-4169 shows promise to treat secondary hyperparathyroidism in phase I trial
Read More
Aoxing confirms enrollment progress for phase III trial of TJSL capsules
Read More
Archer Biosciences begins dosing in third cohort of TPI-287 trial in metastatic melanoma
Read More
CytRx advances its bafetinib program in oncology
Read More
Seattle Genetics and Agensys begin phase I ASG-5ME trial in pancreatic cancer
Read More
German scientists disclose new HIF-mediated transcription inhibitors
Read More
Boehringer Ingelheim discovers new CB2 receptor agonists
Read More
Aegera reports survival data from phase I AEG-35156 combination trial
Read More
Inotek describes novel PARP inhibitors
Read More
Health Canada approves Winston Laboratories' Civanex for osteoarthritis pain
Read More
CVI Pharmaceuticals identifies novel lipid-lowering agents
Read More
Acorda Therapeutics receives NIH grant to develop GGF2 in heart failure
Read More
AiCuris presents novel anti-HIV agents
Read More
FDA accepts Mannkind's resubmission of Afrezza NDA
Read More
U.S. DoD funds AVI BioPharma's anti-Ebola and -Marburg virus research
Read More
Sepracor to change name to Sunovion Pharmaceuticals
Read More
FDA advisory committee votes for removal of first-line indication from Avastin label
Read More